Activity
-
🧬🧪🔬 Yesterday, I had the opportunity to attend my first BIO International Convention right in my backyard in #SanDiego! The San Diego Convention…
🧬🧪🔬 Yesterday, I had the opportunity to attend my first BIO International Convention right in my backyard in #SanDiego! The San Diego Convention…
Liked by Masunori Kajikawa
-
I had a great week at #BIO2024. On behalf of Cellusion, I appreciate the opportunity to connect with new friends and reconnect with old friends from…
I had a great week at #BIO2024. On behalf of Cellusion, I appreciate the opportunity to connect with new friends and reconnect with old friends from…
Liked by Masunori Kajikawa
-
Beyond JAPAN 2024 たくさんのご応募ありがとうございました! 🙇♂️ Thank you to everyone who applied to the Beyond Japan 2024 program! We had an overwhelming response…
Beyond JAPAN 2024 たくさんのご応募ありがとうございました! 🙇♂️ Thank you to everyone who applied to the Beyond Japan 2024 program! We had an overwhelming response…
Liked by Masunori Kajikawa
Experience & Education
-
Rebirthel Co.,Ltd.
View Masunori’s full experience
See their title, tenure and more.
or
More activity by Masunori
-
It was a great pleasure to reconnect with visionary GrittGene Therapeutics team in LA. I am excited about exploring cutting-edge innovations…
It was a great pleasure to reconnect with visionary GrittGene Therapeutics team in LA. I am excited about exploring cutting-edge innovations…
Liked by Masunori Kajikawa
-
We are excited to announce a broad license agreement with Eli Lilly and Company to access Alloy's best-in-class ATX-Gx™ and ATX-CLC™ fully human…
We are excited to announce a broad license agreement with Eli Lilly and Company to access Alloy's best-in-class ATX-Gx™ and ATX-CLC™ fully human…
Liked by Masunori Kajikawa
-
J-Net 21にてセルージョンを取り上げていただきました。ぜひ、ご一読いただけますと幸いです。 Cellusion was featured on the article of J-Net 21. We hope you will take the time to read…
J-Net 21にてセルージョンを取り上げていただきました。ぜひ、ご一読いただけますと幸いです。 Cellusion was featured on the article of J-Net 21. We hope you will take the time to read…
Liked by Masunori Kajikawa
-
I am attending the BIO International Convention 2024 in San Diego. If you’re also visiting, I look forward to seeing you there!
I am attending the BIO International Convention 2024 in San Diego. If you’re also visiting, I look forward to seeing you there!
Liked by Masunori Kajikawa
-
武蔵野大学・アントレプレナーシップ学部で、伊藤羊一さんの授業をゲストとして見学させて頂きました！ 落合絵美さん、ご招待頂きありがとうございました！！ これからグローバル展開で色々ご一緒できることを楽しみにしております！ Thank you Professor Yoichi Ito for…
武蔵野大学・アントレプレナーシップ学部で、伊藤羊一さんの授業をゲストとして見学させて頂きました！ 落合絵美さん、ご招待頂きありがとうございました！！ これからグローバル展開で色々ご一緒できることを楽しみにしております！ Thank you Professor Yoichi Ito for…
Liked by Masunori Kajikawa
-
Exciting times at SushiTech 2024! 🎉 We're thrilled to reconnect with all our Beyond Japan 2023 alumni. It was the best catch-up ever, hearing about…
Exciting times at SushiTech 2024! 🎉 We're thrilled to reconnect with all our Beyond Japan 2023 alumni. It was the best catch-up ever, hearing about…
Liked by Masunori Kajikawa
-
🌟 LaunchStarz at SusHiTech Tokyo 2024 🌟🚀 We’re thrilled to be at SusHiTech Tokyo 2024! It’s been incredible catching up with our Beyond Japan…
🌟 LaunchStarz at SusHiTech Tokyo 2024 🌟🚀 We’re thrilled to be at SusHiTech Tokyo 2024! It’s been incredible catching up with our Beyond Japan…
Liked by Masunori Kajikawa
-
Attending BIO 2024? Click below to send TAGCyx Biotechnologies Inc. a meeting request in the BIO partnering system! #BIO2024 https://lnkd.in/guwnw8Hz
Attending BIO 2024? Click below to send TAGCyx Biotechnologies Inc. a meeting request in the BIO partnering system! #BIO2024 https://lnkd.in/guwnw8Hz
Liked by Masunori Kajikawa
-
We, Rebirthel Co., Ltd., will exhibit from JETRO Japan pavilion booth in BIO International Convention 2024 @San Diego on June 3rd-6th. If you are…
We, Rebirthel Co., Ltd., will exhibit from JETRO Japan pavilion booth in BIO International Convention 2024 @San Diego on June 3rd-6th. If you are…
Posted by Masunori Kajikawa
-
Working on a new business project. I am glad I was able to participate in Berkeley SkyDeck last week; one of the best startup accelerators from…
Working on a new business project. I am glad I was able to participate in Berkeley SkyDeck last week; one of the best startup accelerators from…
Liked by Masunori Kajikawa
-
Cellusion's lead pipeline, CLS001, has received FDA's Orphan Drug Designation. Cellusion will cooperate with regulatory authorities, such as FDA, to…
Cellusion's lead pipeline, CLS001, has received FDA's Orphan Drug Designation. Cellusion will cooperate with regulatory authorities, such as FDA, to…
Liked by Masunori Kajikawa
-
I am more than happy to share this wonderful news!
I am more than happy to share this wonderful news!
Liked by Masunori Kajikawa
-
Rebirthel Co.,Ltd. are preparing the first clinical trial conducted in humans for acute myeloid leukemia to evaluate safety and efficacy. Learn more…
Rebirthel Co.,Ltd. are preparing the first clinical trial conducted in humans for acute myeloid leukemia to evaluate safety and efficacy. Learn more…
Liked by Masunori Kajikawa
-
I will join the 40th Medicinal Chemistry Symposium to have a presenation. Looking forward to meeting and discussing with you at the conference.
I will join the 40th Medicinal Chemistry Symposium to have a presenation. Looking forward to meeting and discussing with you at the conference.
Liked by Masunori Kajikawa
Other similar profiles
-
Kazuyoshi MIYAWAKI
Co-Founder / Managing Director at Physiologas Technologies Inc.
Connect -
Takehito Matsuba
Connect -
Emiko Hatanaka
Rebirthel Co., Ltd. - General Affairs / Business Development
Connect -
Kohei Katsurasako
MBA student at Doshisha University
Connect -
Satoshi Miyagawa
Connect -
Hajime Murano
Connect -
Tadashi/禎 Miyahara/宮原
Connect -
Kentaro Hayashi
HICKY, Inc.-CEO, Tokyo Biodesign, The University of Tokyo- Pediatric Surgeon,
Connect -
Kenny Lum
Connect -
Reo Maeda
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More